ELAN Elanco Animal Health Incorporated Common Stock Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
16:41
Aug 16
Aug 16
Bloomberg Markets
Pet longevity trend boosts animal-health companies
Pet owners are applying human longevity and wellness trends to pets, supporting a large and expanding market; US pet spending is around $165 billion with the pet supplement market at $2.9 billion, and companies like Loyal and Elanco are working on longevity drugs and disease treatments that could add years to pets' lives.
ELAN
Elanco Animal Health Incorporated Common Stock
Long
—
—
13:51
Aug 16
Aug 16
Bloomberg Markets
Elanco's pet longevity pipeline can add years.
Elanco's CEO says the industry has already extended pet lifespans through better care, vaccines and nutrition, and Elanco is working on treatments for diseases that kill pets, which could add another five to ten years and supports the company's animal health pipeline.
ELAN
Elanco Animal Health Incorporated Common Stock
Long
1ST
—
—
22:11
Aug 06
Aug 06
Bloomberg Markets
Innovation drives raised guidance
Elanco raised full-year guidance as all segments grow, driven by innovation in pet health (dermatology, Credelio, new parasiticide products) and strong demand. The pet owner remains willing to spend on health, supporting price and volume growth.
ELAN
Elanco Animal Health Incorporated Common Stock
Long
—
—
About ELAN Investor Commentary
Across the available history and selected sources, Buzzberg tracks ELAN (Elanco Animal Health Incorporated Common Stock) across 5 sources: 9 bullish vs 0 bearish calls from 6 authors. Historical directional balance: 75% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 12 total trade ideas tracked. Latest voices: Anna Edney, Jeff Simmons.